Drug Shortage Report for ACYCLOVIR SODIUM INJECTION
| Report ID | 111367 |
| Drug Identification Number | 02236926 |
| Brand name | ACYCLOVIR SODIUM INJECTION |
| Common or Proper name | Acyclovir Sodium Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ACYCLOVIR |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | Vial 20 mL |
| ATC code | J05AB |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2020-04-01 |
| Estimated end date | Unknown |
| Actual end date | 2020-08-14 |
| Shortage status | Resolved |
| Updated date | 2020-08-17 |
| Company comments | Our stock of Acyclovir Sodium Injection 50 mg/mL, 10 mL and 20 mL vials is expected to deplete by August 14, 2020. The product will remain on reduced allocation until stock is depleted. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-08-17 | French | Compare |
| v3 | 2020-08-17 | English | Compare |
| v2 | 2020-04-07 | French | Compare |
| v1 | 2020-04-07 | English | Compare |
Showing 1 to 4 of 4